Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial dysfunction in acute hyperammonemia.

Vicente Felipo1, Roger F Butterworth

  • 1Instituto Investigaciones Citologicas de la Fundacion Valenciana de Investigaciones Biomedicas, Valencia, Spain.

Neurochemistry International
|February 19, 2002
PubMed
Summary

Acute hyperammonemia severely impacts brain function by disrupting energy metabolism and activating specific receptors. NMDA receptor antagonists and NOS inhibitors show promise in preventing seizures and mortality associated with this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicles from plasma of patients with minimal hepatic encephalopathy induce neuroinflammation and cognitive impairment in rats, which are prevented by treating the patients with rifaximin.

Journal of neuroinflammation·2026
Same author

Hyperammonemia reduces the populations of beneficial lactobacilli and bifidobacteria, disrupting the metabolic balance of the gut microbiome in rats.

Frontiers in microbiology·2026
Same author

Hyperammonemia increases the release of pathological extracellular vesicles from monocytes by impairing lysosomal function and autophagy through the TNFα-cAMP-PKA-LC3 pathway.

Frontiers in immunology·2026
Same author

Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Mechanisms by which neuroinflammation modulates GABAergic neurotransmission in the hippocampus of hyperammonemic rats.

Neurotoxicology·2025
Same author

Golexanolone affords sustained improvement of Parkinson's symptoms in rats by reducing microglia activation that restores the glutamate-GABA-dopamine pathway.

Neuropharmacology·2025

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • Acute hyperammonemia, caused by urea cycle disorders, Reye syndrome, or liver failure, leads to severe neurological impairment, seizures, and death.
  • Ammonia impairs mitochondrial energy production by inhibiting alpha-ketoglutarate dehydrogenase and activates NMDA receptors, contributing to neuronal dysfunction.

Purpose of the Study:

  • To investigate the mechanisms underlying acute hyperammonemia-induced neuronal dysfunction.
  • To evaluate the therapeutic potential of NMDA receptor antagonists and NOS inhibitors in mitigating hyperammonemia's toxic effects.

Main Methods:

  • Examined the effects of ammonia on the tricarboxylic acid cycle and mitochondrial function.
  • Assessed the impact of NMDA receptor antagonists and NOS inhibitors on ammonia-induced seizures, mortality, and metabolic changes.

Related Experiment Videos

  • Investigated ammonia's effects on free radical scavenging enzymes, peripheral-type benzodiazepine receptors, and monoamine oxidase-B.

    • Main Results:

    • Ammonia inhibits alpha-ketoglutarate dehydrogenase, disrupting cellular energy metabolism.
    • NMDA receptor antagonists and NOS inhibitors effectively prevent ammonia-induced seizures, mortality, and alterations in mitochondrial calcium homeostasis and energy metabolism.
    • Ammonia exposure decreases free radical scavenging enzyme activity, which is counteracted by NMDA receptor antagonists and NOS inhibitors.
    • Ammonia activates mitochondrial enzymes (peripheral-type benzodiazepine receptors, monoamine oxidase-B) in astrocytes, leading to mitochondrial swelling and altered monoamine metabolism.

    Conclusions:

    • Acute hyperammonemia causes significant neuronal dysfunction through mechanisms involving energy metabolism disruption and receptor activation.
    • NMDA receptor antagonists and NOS inhibitors represent potential therapeutic strategies for managing acute hyperammonemia syndromes.
    • Mitochondrial dysfunction, including swelling and altered enzyme activity, plays a critical role in the neurotoxicity of acute hyperammonemia.